Intravenous Amiodarone for Incessant Tachyarrhythmias in Children
Author(s) -
J. Philip Saul,
William Scott,
Stephen Brown,
Pablo Marantz,
Valeria Acevedo,
Susan P. Etheridge,
James C. Perry,
John K. Triedman,
Susan W. Burriss,
Paul Cargo,
Jay Graepel,
Eeva-Kaarina Koskelo,
Rebecca Wang
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.105.534149
Subject(s) - medicine , amiodarone , adverse effect , bradycardia , ventricular tachycardia , anesthesia , vomiting , nausea , tachycardia , atrial flutter , dosing , supraventricular arrhythmia , clinical endpoint , randomized controlled trial , cardiology , heart rate , atrial fibrillation , blood pressure
Intravenous (IV) amiodarone has proven efficacy in adults. However, its use in children is based on limited retrospective data.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom